| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $260K | -49.8% | +126.1% |
| Cost of Revenue | $121K | -28.0% | +181.4% |
| Gross Profit | $139K | -60.3% | +178.0% |
| R&D Expense | $3.9M | +18.2% | +37.7% |
| SG&A Expense | $2.5M | -3.9% | -0.8% |
| Operating Income | -$11.0M | -12.3% | +18.3% |
| Income Tax | $0 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $18.7M | -23.0% | +455.8% |
| Accounts Receivable | $258K | -49.6% | +23.4% |
| Inventory | $471K | -32.0% | +103.0% |
| Current Assets | $21.4M | -20.3% | +346.3% |
| Total Assets | $43.9M | -13.0% | -37.4% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$16.6M | — | — |
| Capital Expenditures | $1.7M | — | — |
| Investing Cash Flow | -$1.7M | — | — |
| Financing Cash Flow | $28.3M | — | — |
| Free Cash Flow | -$18.3M | — | — |
| — |
| — |
| Net Income | -$10.9M | -11.4% | +19.6% |
| EPS (Basic) | -$0.34 | -13.3% | +65.3% |
| EPS (Diluted) | -$0.34 | -13.3% | +65.3% |
| $7.7M |
| +15.2% |
| -15.7% |
| Total Liabilities | $53.1M | +7.5% | -12.2% |
| Stockholders' Equity | -$9.2M | -937.5% | -194.7% |